Can a laparoscopic myomectomy be the precipitating factor for an acute deep‑vein thrombosis occurring one month after surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Laparoscopic Myomectomy Cause DVT One Month Post-Surgery?

Yes, laparoscopic myomectomy can absolutely be the precipitating factor for deep vein thrombosis occurring one month after surgery, as postoperative hypercoagulability persists for up to 30 days following major abdominopelvic procedures.

Understanding the Extended Risk Window

The risk of VTE does not end at hospital discharge. Postoperative hypercoagulability has been demonstrated to persist for 30 days following major abdominopelvic surgery 1. A classic study showed that 13 of 51 patients (25%) who were DVT-free at discharge developed thrombosis during the 6-week postoperative period 2. This means your patient's DVT at one month falls squarely within the established high-risk window.

Laparoscopic Surgery-Specific Risk Factors

Laparoscopic procedures carry unique thrombogenic mechanisms:

  • Pneumoperitoneum effects: Increased intra-abdominal pressure directly impairs venous return from lower extremities 3
  • Trendelenburg positioning: Further compromises venous flow dynamics 3
  • Activation of hemostatic system: The procedure itself triggers coagulation cascades 3

While some studies suggest gynecologic laparoscopic procedures have relatively low VTE rates 4, these studies typically assessed only immediate postoperative periods and used prophylaxis protocols.

The Myomectomy-Specific Data

Population-based data from South Korea analyzing 23,549 myomectomies found VTE incidence rates of 5.7 per 10,000 patients, with DVT specifically at 4.4 per 10,000 5. However, these are detected cases—the true incidence may be higher since many patients are discharged before symptoms develop 3.

Critical Timeline Considerations

The timing of your patient's DVT (one month post-op) is particularly significant:

  • Risk factors persist for several weeks after surgery 2
  • Most major abdominopelvic surgery guidelines recommend extended thromboprophylaxis for 28-30 days 1
  • The fact that guidelines recommend this duration specifically acknowledges the persistent risk through this timeframe

Was Prophylaxis Provided?

The key question is whether this patient received appropriate thromboprophylaxis. Current guidelines suggest extended duration thromboprophylaxis (up to 28-30 days) for high-risk patients undergoing major abdominopelvic surgery 1.

For laparoscopic myomectomy specifically:

  • If the patient had additional risk factors (obesity, prior VTE, thrombophilia, prolonged operative time, cancer), extended prophylaxis should have been considered
  • Standard practice often provides only in-hospital prophylaxis, which leaves a significant gap in coverage 4

Clinical Bottom Line

Your laparoscopic myomectomy is the most likely precipitating cause of this DVT because:

  1. The timing (one month) falls within the established 30-day hypercoagulable window
  2. Laparoscopic surgery has specific thrombogenic mechanisms
  3. The procedure qualifies as major abdominopelvic surgery with recognized VTE risk
  4. No other obvious provoking factors are mentioned

What This Means for Management

  • Treat this as a provoked VTE (surgery-related)
  • Standard anticoagulation duration: minimum 3 months 6
  • After completing initial treatment, assess for extended prophylaxis needs based on individual risk factors
  • Document this event for future surgical planning—this patient now has a history of postoperative VTE, placing them at higher risk (HR 3.4 for factor V Leiden carriers, HR 2.7 for males) for recurrence with future procedures 7

Prevention Lesson

This case highlights the gap between guideline recommendations for extended thromboprophylaxis and actual clinical practice 1. While extended prophylaxis adoption remains low, cases like this demonstrate why the 28-30 day window matters, particularly for patients with additional risk factors.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.